Cargando…
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
Cancer-immunotherapy targeting programmed cell death 1 (PD-1) activates tumor-specific T cells and provides clinical benefits in various cancers. However, the molecular basis of PD-1 function is still enigmatic. Especially, it is unclear which signaling pathway PD-1 primarily targets. Besides, the c...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455061/ https://www.ncbi.nlm.nih.gov/pubmed/31001256 http://dx.doi.org/10.3389/fimmu.2019.00630 |